Literature DB >> 1841864

Anti-trichomonad IgA antibodies in trichomoniasis before and after treatment.

P Sharma1, N Malla, I Gupta, N K Ganguly, R C Mahajan.   

Abstract

Anti-trichomonad IgA antibodies were estimated by enzyme-linked immunosorbent assay (ELISA) in serum and vaginal secretions of 25 symptomatic and 25 asymptomatic Trichomonas vaginalis positive patients before and after treatment and in 25 age-matched controls. Significantly higher levels of antitrichomonad IgA antibodies were found in T. vaginalis positive patients when compared to control subjects, especially in vaginal secretions. In addition, a significant decrease in these antibodies was observed after treatment, which was more pronounced in vaginal secretions. It seems that anti-trichomonad IgA antibodies in serum and more so in vaginal secretions are directly related to and specific to the presence of T. vaginalis in the urogenital tract.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1841864     DOI: 10.1007/bf02814365

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  8 in total

1.  The influence of local infection on immunoglobulin formation in the human endocervix.

Authors:  E J Chipperfield; B A Evans
Journal:  Clin Exp Immunol       Date:  1972-06       Impact factor: 4.330

Review 2.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

3.  Immunofluorescence demonstration of antibodies in urogenital trichomoniasis.

Authors:  J Kramár; K Kucera
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1966

4.  Antitrichomonal antibody in the vaginal secretions of women infected with T. vaginalis.

Authors:  J P Ackers; W H Lumsden; R D Catterall; R Coyle
Journal:  Br J Vener Dis       Date:  1975-10

5.  Enzyme linked immunosorbent assay for detecting antibody to Trichomonas vaginalis: use of whole cells and aqueous extract as antigen.

Authors:  J F Alderete
Journal:  Br J Vener Dis       Date:  1984-06

6.  Antibody to Trichomonas vaginalis in human cervicovaginal secretions.

Authors:  K E Su
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions.

Authors:  D A Street; D Taylor-Robinson; J P Ackers; N F Hanna; A McMillan
Journal:  Br J Vener Dis       Date:  1982-10

8.  Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis.

Authors:  A C Fouts; S J Kraus
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

  8 in total
  5 in total

Review 1.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis.

Authors:  D Provenzano; J F Alderete
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

3.  Antitrichomonas IgG, IgM, IgA, and IgG subclass responses in human intravaginal trichomoniasis.

Authors:  Simernjeet Kaur; Sumeeta Khurana; Rashmi Bagga; Ajay Wanchu; Nancy Malla
Journal:  Parasitol Res       Date:  2008-04-24       Impact factor: 2.289

4.  Reactive nitrogen intermediates in experimental trichomoniasis induced with isolates from symptomatic and asymptomatic women.

Authors:  Nancy Malla; Zarrintaj Valadkhani; Kusum Harjai; Saroj Sharma; Indu Gupta
Journal:  Parasitol Res       Date:  2004-09       Impact factor: 2.289

Review 5.  Trichomoniasis immunity and the involvement of the purinergic signaling.

Authors:  Camila Braz Menezes; Tiana Tasca
Journal:  Biomed J       Date:  2016-09-21       Impact factor: 4.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.